Literature DB >> 8453923

Esophageal carcinoma: impact of staging on treatment.

J R Siewert1, H J Dittler.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8453923     DOI： 10.1055/s-2007-1010263

Source DB:  PubMed          Journal:  Endoscopy        ISSN： 0013-726X            Impact factor:   10.093


× No keyword cloud information.
  8 in total

Review 1.  Staging gastrointestinal cancer as a precondition for multimodal treatment.

Authors:  J R Siewert; A Sendler; H J Dittler; U Fink; H Höfler
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 2.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

3.  A study comparing endoscopic ultrasound (EUS) and computed tomography (CT) in staging oesophageal cancer and their role in clinical decision making.

Authors:  Duminda Subasinghe; Dharmabandhu Nandadeva Samarasekera
Journal:  J Gastrointest Cancer       Date:  2010-03

Review 4.  Esophageal cancer, early disease: diagnosis and current treatment.

Authors:  H D Becker
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

Review 5.  Staging of squamous esophageal cancer: accuracy and value.

Authors:  A H Hölscher; H J Dittler; J R Siewert
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

6.  Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis.

Authors:  Wolfgang Schröder; Stephan E Baldus; Stefan P Mönig; Tobias K E Beckurts; Hans P Dienes; Arnulf H Hölscher
Journal:  World J Surg       Date:  2002-02-19       Impact factor: 3.352

7.  Role of endoscopic ultrasound in the preoperative assessment of patients with oesophageal cancer.

Authors:  J Vickers
Journal:  Ann R Coll Surg Engl       Date:  1998-07       Impact factor: 1.891

8.  Positron emission tomography for staging of oesophageal and gastroesophageal malignancy.

Authors:  A C Kole; J T Plukker; O E Nieweg; W Vaalburg
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.